← All Ataibeckley INC filings

Ataibeckley INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley COO Reports Stock Transaction
Gerd Kochendoerfer, Chief Operating Officer of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Executive Reports Stock Transaction
Kevin James Craig, Chief Medical Officer of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Executive Reports Stock Transaction
Anne Nagengast Johnson, Chief Accounting Officer of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Executive Reports Stock Transaction
Christopher Ryan Cave Barrett, See remarks of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Executive Reports Stock Transaction
Glenn Frank Short, Chief Scientific Officer of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley CFO Reports Stock Transaction
Michael E. Faerm, Chief Financial Officer of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Laurent Fischer, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
John Francis Hoffman, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Amir H Kalali, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Andrea Heslin Smiley, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Scott Braunstein, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Executive Reports Stock Transaction
Srinivas Rao, See remarks and a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Robert Hershberg, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Director Reports Stock Transaction
Sabrina Martucci Johnson, a Director of AtaiBeckley Inc., reported multiple transactions in common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: AtaiBeckley Insider Reports Stock Transaction
Christian Angermayer and 1 other reported changes in beneficial ownership of AtaiBeckley Inc. common stock on September 11, 2026.
NASDAQ
ATAI
Ataibeckley INC
Form 4: Atai Life Sciences Director Trades Under 10b5-1 Plan
Atai Life Sciences Director Robert Hershberg executed a Rule 10b5-1 trading plan, involving the exercise of stock options and sale of common stock.